Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer

By Zent O.   Banzhoff A.   Hilbert A.K.   Meriste S.   Sluzewski W.   Wittermann C.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3584-3592

Elsevier

Access to resources Recommend Favorite

Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains

By Hayasaka D.   Goto A.   Yoshii K.   Mizutani T.   Kariwa H.   Takashima I.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4774-4779

Elsevier

Access to resources Recommend Favorite

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

By Ehrlich H.J.   Pavlova B.G.   Fritsch S.   Poellabauer E.-M.   Loew-Baselli A.   Obermann-Slupetzky O.   Maritsch F.   Cil I.   Dorner F.   Barrett P.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children

By Eder G.   Kollaritsch H.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3575-3583

Elsevier

Access to resources Recommend Favorite

Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study

By Girgsdies O.E.   Rosenkranz G.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1421-1428

Elsevier

Access to resources Recommend Favorite